Showing 6901-6910 of 8649 results for "".
- Maui Jim and VSP Global Expand Relationship to Include Maui Jim Inside the VSP Formularyhttps://modernod.com/news/maui-jim-and-vsp-global-expand-relationship-to-include-maui-jim-inside-the-vsp-formulary/2479547/Maui Jim, the sunglass and eyewear supplier, announced “a significant step forward in its ongoing relationship with VSP Global,” reporting that Maui Jim will officially be available within the VSP formulary and will be included in the VSP contract lab network, according to a VisionMon
- Forbes: Will Your iPhone’s Dark Mode Save Your Eyes?https://modernod.com/news/forbes-will-your-iphones-dark-mode-save-your-eyes/2476786/Eye care has come a long way. From cataract surgery to Lasik, we can do more than ever before to return sight to those who once would have lost it. These days, it seems like there’s always a new breakthrough around the corner—here’s a roundup of some of the biggest trends in eye care and what the
- Peripapillary Retinal Nerve Thinning Faster in People With Diabeteshttps://modernod.com/news/peripapillary-retinal-nerve-thinning-faster-in-people-with-diabetes/2476787/People with type 2 diabetes show accelerated thinning of the peripapillary retinal nerve fiber layer (pRNFL), even in the absence of diabetic retinopathy (DR), according to South Korean researchers, Reuters Health reported. “
- B+L Introduces FreeFlow Infusion System and 23-Gauge Bi-Blade Dual Port Vitrectomy Cutterhttps://modernod.com/news/bausch-lomb-introduces-freeflow-infusion-system-for-retina-surgery/2476761/Bausch + Lomb announced the launch of the FreeFlow infusion system for retina surgery and the 23-gauge Bi-Blade dual port vitrectomy cutter for the Stellaris Elite vision enhancement system. The FreeFlow infusion system allows for higher level of infusion flow compared to previous generati
- US Judge Invalidates Rule Requiring Drugmakers to Disclose Price of Medicines in TV Adshttps://modernod.com/news/us-judge-invalidates-rule-requiring-drugmakers-to-disclose-price-of-medicines-in-tv-ads/2479564/A judge in the US District Court for the District of Columbia invalidated a rule that was scheduled to come into effect on July 9 requiring dire
- EyecareLive Unveils Enhanced Responsible Telemedicine Platform for Optometry and Ophthalmologyhttps://modernod.com/news/eyecarelive-unveils-enhanced-responsible-telemedicine-platform-for-optometry-and-ophthalmology/2476674/EyecareLive announced the release of EyecareLive 2.0. EyecareLive was built by doctors, for doctors, with a mission to strengthen the doctor-patient relationship by providing a comprehensive telemedicine platform that enhances patient care. The launch will also feature EyecareLive’s
- Glaucoma Drugs Continue to Battle for Market Sharehttps://modernod.com/news/glaucoma-drugs-continue-to-battle-for-market-share/2476655/Two new glaucoma drugs introduced in the US in 2018 continue to battle for market share. Rhopressa, from Aerie Pharmaceuticals, got out of the gate faster than Vyzulta from Bausch Health. The growth rate for both drugs slowed in the first quarter of 2019, which is normal after a product launch, a
- First Patient Dosed in Phase 2 Trial Evaluating Ocular Delivery of ST266 For the Treatment of Persistent Corneal Epithelial Defectshttps://modernod.com/news/noveome-biotherapeutics-announces-the-first-patient-dosed-in-phase-2-open-label-clinical-trial-evaluating-topical-ocular-delivery-of-st266-for-the-treatment-of-persistent-corneal-epithelial-defects/2476652/Noveome Biotherapeutics announced the dosing of the first patient in its phase 2 open label, multicenter clinical trial evaluating topical ocular delivery of ST266 for the treatment of persistent corneal epithelial defects (PEDs), for which there are limited treatment options. “The dosing
- Pioneering Ophthalmologist Patricia Bath, MD, Dies at 76https://modernod.com/news/pioneering-ophthalmologist-patricia-bath-md-dies-at-76/2476632/Patricia E. Bath, MD, an ophthalmologist who took a special interest in combating preventable blindness in underserved populations and became the first black female doctor to patent a medical invention, a laser device for treating cataracts, died at the age of 76, acc
- Goldman Sachs Unit to Buy 575 Optometry Practices in $2.7 Billion Dealhttps://modernod.com/news/report-goldman-sachs-unit-to-buy-capital-vision-services-in-2-7-billion-deal/2476625/In one of the largest optometry deals to date, the merchant-banking division of Goldman Sachs Group (West Street Capital Partners VII) announced that it is buying Capital Vision Services, which operates 575 optometry practices, from private-equity firm Altas Partners LP and Canadian pension fund